Susan Hasty, Publisher
Table of Contents . . . August 14th, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Bioterrorism - Method to retrospectively identify ricin in animal tissues has been developed
Poxvirus Vaccine - Cross-reactive variant peptide encoded by mousepox virus has been identified
Smallpox Vaccine - Immunity against secondary poxvirus infection depends on antibody, not on CD4 or CD8 function
Allergy & Immunology - Researchers identify the series of events leading to the large-scale immune response to disease
Business Update - ImmuneRegen appoints Investor Awareness to launch investor relations program
Personnel - Dr. Harold Handley appointed president of Aethlon Medical, Inc.
Smallpox Vaccine - Antibody prevents poxvirus from forming pock lesions that promote virus transmission
Smallpox Vaccine - Human leukocyte antigen-A2-restricted CD8+ CTL responses to vaccinia virus epitope are examined
Smallpox Vaccine - Immunity and immunological memory following smallpox vaccination are reviewed
Vaccinia Virus - Effect of UTP sugar and base modifications on vaccinia virus early gene transcription are examined
Yersinia Pestis Drug Development - ATP-binding cassette transporter protein OppA protects against Yersinia pestis infection
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.